The elevated serum levels of alkaline phosphatase (ALP), which is known to be the most predictive biological marker for the presence of bone metastases in GC, together with the presence of elevated tumor markers, such as carcinoembryonic antigen (CEA) and CA19-9, suggest the need for skeletal screening [78]. This evidence concerns the gene CEACAM5 and gastric cancer.